Date: 2017-06-29
Type of information: Nomination
Compound: Chief Medical Officer, Head of CMC Regulatory Affairs, Chief Financial Officer
Company: Horama (France)
Therapeutic area: Rare diseases - Genetic diseases - Ophtalmological diseases
Type agreement: nomination
Action mechanism:
Disease:
Details:
- • On June 29, 2017, Horama announced the appointment of three new experts: Jean-Yves Deslandes, Nicolas Delaunay and Jérôme Vailland. With these three notable additions, the company, founded in 2014 with the ambition to treat inherited retinopathies, a class of rare eye diseases, completes its management team.
- Jean – Yves Deslandes, Chief Medical Officer, joined Horama in April 2017. He has over 25 years of international experience in the pharmaceutical industry in Europe and the United States, including significant experience in ophthalmology and ocular gene therapy. His past positions include Clinical Research Manager at Alcon/Novartis, Director of Clinical Research at Sanofi – Fovea and Director of the Department of Clinical Research at Allergan Europe. He has a M.D. degree from the University of Paris VII.
- Nicolas Delaunay, Head of CMC Regulatory Affairs, has been hired by Horama in November 2016. Nicolas Delaunay is an expert in the management of pharmaceutical development projects for gene – therapy products . During his 13 – year tenure at Généthon, Nicolas contributed to the implementation of Généthon’s Pharmaceutical Quality System, before assuming the responsibility of Quality Manager as Delegate Chief Pharmacy Officer. He was in charge of certifying batches of experimental gene – therapy products (ATMP) . The Agence Nationale de Sécurité du Médicament et des Produits de Santé (AN SM) then hired him as Clinical Evaluator in ophthalmology. He has a Ph.D. in Pharmacy from the University of Paris XI and two Master’s Degree : one in Quality Control and Assurance for gene and cell therapy products and one in Public Health, with a major in Health Economics .
- Jérôme Vailland, Chief Financial Officer, has been hired in November 2016. He has 15 years of experience in audit, management and transactions . Following his career start as a Financial Controller at Bouygues Telecom, he was hired as a Senior Manager by Ernst & Young, where he worked during 11 years in the fields of financial audit, transaction advisory services and IPO services, mainly for the life sciences industry, in addition to his m anagerial duties (team management, business development, recruitment, etc.). Jérôme Vailland is a graduate of Audencia – Nantes, where he majored in audit – financial control.
Financial terms:
Latest news:
Is general: Yes
